In a regulatory filing, PetVivo disclosed that the company and ThinkEquity mutually agreed to terminate the ATM sales agreement, dated as of August 23, 2023 between the company and with ThinkEquity as the agent, effective as of March 7. Subject to the terms and conditions of the ATM agreement, the company could from time to time offer and sell shares of the company’s common stock having an aggregate offering price of up to $2,500,000 through the agent in “at-the-market offerings” as defined in Rule 415 of the Securities Act of 1933, as amended. Prior to termination, the company issued and sold 674,000 shares of its common stock under the ATM agreement, raising net proceeds of $959,033, the filing noted.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PETV:
- Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer
- PetVivo commences trading on Upstream under PETV
- PetVivo announces study results involving Spryng
- Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California
- PetVivo approved to dual list on Upstream